NEURODEGENERATIVE DISEASES
Clinical trials for NEURODEGENERATIVE DISEASES explained in plain language.
Never miss a new study
Get alerted when new NEURODEGENERATIVE DISEASES trials appear
Sign up with your email to follow new studies for NEURODEGENERATIVE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Alzheimer's drug targets brain inflammation in major trial
Disease control CompletedThis completed Phase 2 study tested whether the drug XPro1595 could help slow cognitive decline in people with early Alzheimer's disease who show signs of brain inflammation. 208 participants with mild Alzheimer's or mild cognitive impairment received either the drug or a placebo…
Matched conditions: NEURODEGENERATIVE DISEASES
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Extended trial tests promising drug for genetic muscle disease
Disease control CompletedThis study continued testing an experimental drug called AOC 1001 in adults with myotonic dystrophy type 1, a genetic muscle-wasting disease. It followed 37 participants from a previous trial to check long-term safety and see if the drug continues to work when given every 8 weeks…
Matched conditions: NEURODEGENERATIVE DISEASES
Phase: PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New scan could spot rare nerve disorder faster
Diagnosis CompletedThis study tested whether a simple, non-invasive ultrasound scan could help doctors diagnose a rare genetic condition called CANVAS. CANVAS causes problems with balance, coordination, and sensation due to nerve damage. Researchers compared ultrasound images of nerves in 35 people…
Matched conditions: NEURODEGENERATIVE DISEASES
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Diagnosis
Last updated Mar 30, 2026 14:35 UTC
-
Can a daily pill boost brainpower? scientists test NAD+ in women
Knowledge-focused CompletedThis study tested whether a daily NAD+ supplement could improve thinking skills or change certain health markers in the blood. It involved 53 healthy women aged 40-80 who took either the supplement or a placebo pill for four weeks. Researchers measured participants' memory and th…
Matched conditions: NEURODEGENERATIVE DISEASES
Phase: NA • Sponsor: University of Rhode Island • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC